• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:孔学礼,胡颖玥,孙亚茹,杨浩鑫,张旋.炎琥宁对脂多糖诱导急性肺损伤的防治作用及机制[J].药学研究,2026,45(4):361-366,380[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2194次   下载 852次 本文二维码信息
码上扫一扫!
炎琥宁对脂多糖诱导急性肺损伤的防治作用及机制
孔学礼1,2,胡颖玥1,孙亚茹1,杨浩鑫1,张旋1
字体:加大+|默认|缩小-
(1.昆明医科大学药学院暨云南省天然药物药理重点实验室/云南省现代生物医药产业学院,云南 昆明 650500;2.云南省药品和医疗器械审评中心,云南 昆明 650101)
摘要:
目的 采用气管滴注脂多糖 (lipopolysaccharide,LPS)的方法构建小鼠急性肺损伤(acute lung injury, ALI)动物模型,研究注射用炎琥宁对急性肺损伤的防治作用及机制。方法 随机将小鼠分成6组,给药造模后采集小鼠的肺泡灌洗液(BALF)和肺组织标本。检测BALF中白细胞介素-6(IL-6)等6项炎症指标。对病理切片进行炎症评分。检测肺组织中丙二醛(MDA)和超氧化物歧化酶(SOD)。PCR检测Toll样受体4(TLR4)、含pyrin结构域NOD样受体家族3(NLRP3)、核因子κB(NF-κB)p65、c-Jun氨基端激酶(JNK)、细胞外调节蛋白激酶(Erk1/2)、p38对应mRNA表达水平。蛋白印迹法(Western blotting)测NLRP3、TLR4、NF-κB p65、JNK、Erk1/2、p38蛋白表达水平。结果 与LPS模型组比较,注射用炎琥宁能够改善ALI小鼠模型肺组织损伤程度,降低病理组织形态学炎症评分,减轻炎症反应;可提升ALI小鼠肺组织内的SOD活力,降低MDA含量;可以使ALI小鼠BALF中的总细胞数量、总蛋白浓度,细胞炎症因子IL-1β、IL-6、TNF-α的含量水平下降;TLR4、NLPR3、NF-κB p65和JNK、ErK1/2、p38蛋白及mRNA表达水平下调。结论 炎琥宁能减轻LPS诱导的ALI小鼠肺损伤程度,抑制肺部炎症反应,减轻氧化损伤,增强抗氧化能力。炎琥宁对ALI的防治作用机制与抑制TLR4/NF-κB和MAPK信号通路激活有关。
关键词:  注射用炎琥宁  急性肺损伤  丝裂原活化蛋白激酶  Toll样受体4/核因子κB  氧化应激
DOI:10.13506/j.cnki.jpr.2026.04.001
基金项目:国家自然科学基金项目(No.82260727);昆明医科大学科技创新团队项目(No.CXTD2022003)
收稿日期:2025-11-19   修回日期:2026-01-07   出版日期:2026-04-30
Preventive effects and mechanisms of Yanhuning on lipopolysaccharide-induced acute lung injury
KONG Xueli1,2,HU Yingyue1,SUN Yaru1,YANG Haoxin1,ZHANG Xuan1
(1.School of Pharmaceutical Science , Kunming Medical University and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming 650500, China; 2.Yunnan Provincial Center for Drug and Medical Device Evaluation, Kunming 650101, China)
Abstract:
Objective To establish a murine model of acute lung injury (ALI) via intratracheal instillation of lipopolysaccharide (LPS) and investigate the therapeutic/preventive effects and underlying mechanism of Yanhuning for Injection on ALI.Methods The mice were randomly divided into six groups, following drug administration and modeling, bronchoalveolar lavage fluid (BALF) and lung tissue specimens were collected from each group. Six inflammatory markers, including IL-1β, IL-6 and TNF-α,etc, were measured in the BALF. Histopathological sections were scored for inflammation. The content of MDA and the activity of SOD in the tissues were measured. RT-qPCR was used to detect the mRNA expression levels of TLR4, NLRP3, NF-κB p65, JNK, Erk1/2, and p38. Western blotting was employed to determine the protein expression levels of NLRP3, TLR4, NF-κB p65, JNK, Erk1/2 and p38.Results Compared to the LPS model group, Yanhuning for Injection ameliorated lung tissue damage, reduced histopathological inflammation scores, and attenuated the inflammatory response in the ALI mouse model. It significantly increased the SOD activity and decreased the MDA content in the model group. It also significantly reduced the total cell count, total protein concentration, and the levels of inflammatory cytokines IL-1β, IL-6, and TNF-α in the model group. The expression levels of TLR4, NLRP3, NF-κB p65, JNK, Erk1/2, p38 proteins, and their corresponding mRNAs were markedly downregulated.Conclusion Yanhuning can significantly alleviate the degree of lung injury in LPS-induced ALI mice, inhibit pulmonary inflammatory responses, reduce oxidative damage, and enhance antioxidant capacity. The mechanism of Yanhuning's preventive effects on ALI is related to the inhibition the activation of TLR4/NF-κB and MAPK signaling pathway.
Key words:  Yanhuning for Injection  Acute lung injury  MAPK  TLR4/NF-κB  Oxidative stress
今日访问量:2274    总访问量:55338616
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司